Participant flow

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis · Source last updated 2026-06-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Participants were enrolled, assigned to Arm/Cohort = 1/Peritoneal Carcinomatosis Arm = 1/Intraperitoneal (IP) Catheter Placement and Bidirectional Chemotherapy Dose Level = DL 1 intravenous (IV) Paclitaxel Cycle 1 Day 2 (C1D2) 60mg/m\^2 then 80mg/m\^2 DL 1 intraperitoneal (IP) Paclitaxel Cycles 1-3 60mg/m\^2 then Cycles 4-6 80mg/m\^2 DL 1 by mouth (PO) Nilotinib 300mg twice a day (BID). Participants enrolled, assigned to an Arm/Cohort, and start protocol treatment.

   id

   FG000

   title

   Participants Enrolled, Assigned to Cohort 1/Arm 1 Peritoneal Carcinomatosis, and Treated

2. description

   Participants were enrolled, assigned to Arm/(Cohort = 1/Peritoneal Carcinomatosis Arm = 1/Intraperitoneal (IP) Catheter Placement and Bidirectional Chemotherapy Dose Level = DL 1 intravenous (IV) Paclitaxel Cycle 1 Day 2 (C1D2) 60mg/m\^2 then 80mg/m\^2 DL 1 intraperitoneal (IP) Paclitaxel Cycles 1-3 60mg/m\^2 then Cycles 4-6 80mg/m\^2 DL 1 by mouth (PO) Nilotinib 300mg twice a day (BID)); but opted to come off-study prior to start of protocol treatment.

   id

   FG001

   title

   Participants Enrolled, Assigned to an Arm/Cohort, But Not Treated

3. description

   Participants were enrolled, were not assigned to an Arm/Cohort and were not treated.

   id

   FG002

   title

   Participants Enrolled, Not Assigned to an Arm/Cohort and Not Treated

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         2

      3. group Id

         FG002

         num Subjects

         0

      type

      Refused further treatment

   2. reasons

      1. group Id

         FG000

         num Subjects

         4

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      type

      Stopped treatment before completing 6 cycles of therapy due to clinical progression of disease.

   3. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         8

      type

      Ineligible

   4. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         3

      type

      Screen failure

   5. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         1

      type

      Participant refused

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         7

      2. group Id

         FG001

         num Subjects

         2

      3. group Id

         FG002

         num Subjects

         12

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      type

      De-escalated Nilotinib Dose

   3. achievements

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      type

      De-escalated Intravenous (IV) Paclitaxel Dose

   4. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      type

      De-escalated Intraperitoneal (IP) Paclitaxel Dose

   5. achievements

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      type

      COMPLETED

   6. achievements

      1. group Id

         FG000

         num Subjects

         6

      2. group Id

         FG001

         num Subjects

         2

      3. group Id

         FG002

         num Subjects

         12

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice